» Articles » PMID: 35228489

Ultrafast Dynamic Contrast-enhanced MRI of the Breast: How Is It Used?

Overview
Specialty Radiology
Date 2022 Mar 1
PMID 35228489
Authors
Affiliations
Soon will be listed here.
Abstract

Ultrafast dynamic contrast-enhanced (UF-DCE) MRI is a new approach to capture kinetic information in the very early post-contrast period with high temporal resolution while keeping reasonable spatial resolution. The detailed timing and shape of the upslope in the time-intensity curve are analyzed. New kinetic parameters obtained from UF-DCE MRI are useful in differentiating malignant from benign lesions and in evaluating prognostic markers of the breast cancers. Clinically, UF-DCE MRI contributes in identifying hypervascular lesions when the background parenchymal enhancement (BPE) is marked on conventional dynamic MRI. This review starts with the technical aspect of accelerated acquisition. Practical aspects of UF-DCE MRI include identification of target hypervascular lesions from marked BPE and diagnosis of malignant and benign lesions based on new kinetic parameters derived from UF-DCE MRI: maximum slope (MS), time to enhance (TTE), bolus arrival time (BAT), time interval between arterial and venous visualization (AVI), and empirical mathematical model (EMM). The parameters derived from UF-DCE MRI are compared in terms of their diagnostic performance and association with prognostic markers. Pitfalls of UF-DCE MRI in the clinical situation are also covered. Since UF-DCE MRI is an evolving technique, future prospects of UF-DCE MRI are discussed in detail by citing recent evidence. The topic covers prediction of treatment response, multiparametric approach using DWI-derived parameters, evaluation of tumor-related vessels, and application of artificial intelligence for UF-DCE MRI. Along with comprehensive literature review, illustrative clinical cases are used to understand the value of UF-DCE MRI.

Citing Articles

Analysis of the diagnostic efficacy of ultrasound, MRI, and combined examination in benign and malignant breast tumors.

Ma D, Wang C, Li J, Hao X, Zhu Y, Gao Z Front Oncol. 2025; 15:1494862.

PMID: 39949747 PMC: 11821579. DOI: 10.3389/fonc.2025.1494862.


The kinetic parameters of dynamic contrast-enhanced MRI with ultrafast imaging in breast cancer patients receiving neoadjuvant chemotherapy: Prediction of pathologic complete response and correlation with histologic microvessel density.

Choi S, Park A, Kim G, Jung H, Ko K, Kim Y Medicine (Baltimore). 2025; 104(5):e40239.

PMID: 39889156 PMC: 11789864. DOI: 10.1097/MD.0000000000040239.


Superior performance in classification of breast cancer molecular subtype and histological factors by radiomics based on ultrafast MRI over standard MRI: evidence from a prospective study.

Jeong J, Ham S, Seo B, Lee J, Wang S, Bae M Radiol Med. 2025; 130(3):368-380.

PMID: 39862364 PMC: 11903601. DOI: 10.1007/s11547-025-01956-6.


Relationship between kinetic parameters of ultrafast dynamic contrast-enhanced (DCE) MRI and tumor-infiltrating lymphocytes (TILs) in breast cancer.

Yamaguchi K, Nakazono T, Egashira R, Fukui S, Imaizumi T, Maruyama K Jpn J Radiol. 2024; 43(1):43-50.

PMID: 39186213 PMC: 11717854. DOI: 10.1007/s11604-024-01645-w.


Preoperative prediction of extensive intraductal component in invasive breast cancer based on intra- and peri-tumoral heterogeneity in high-resolution ultrafast DCE-MRI.

Luo H, Zhao S, Yang W, Chen Z, Li Y, Zhou P Sci Rep. 2024; 14(1):17396.

PMID: 39075278 PMC: 11286762. DOI: 10.1038/s41598-024-68601-6.


References
1.
Kuhl C, Schrading S, Strobel K, Schild H, Hilgers R, Bieling H . Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol. 2014; 32(22):2304-10. DOI: 10.1200/JCO.2013.52.5386. View

2.
Honda M, Kataoka M, Onishi N, Iima M, Ohashi A, Kanao S . New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing. J Magn Reson Imaging. 2019; 51(1):164-174. DOI: 10.1002/jmri.26838. View

3.
Cuenod C, Balvay D . Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv Imaging. 2013; 94(12):1187-204. DOI: 10.1016/j.diii.2013.10.010. View

4.
Mori N, Abe H, Mugikura S, Miyashita M, Mori Y, Oguma Y . Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer. 2021; 28(5):1141-1153. DOI: 10.1007/s12282-021-01257-6. View

5.
Sheth D, Giger M . Artificial intelligence in the interpretation of breast cancer on MRI. J Magn Reson Imaging. 2019; 51(5):1310-1324. DOI: 10.1002/jmri.26878. View